title: The value of posttransplant monitoring of interleukin (IL)-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23 in the plasma of renal allograft recipients.
abstract: Over the past few years, the central role of cytokines in the amplification of the immune response has been reported and several studies have examined the relationship between the plasma level of individual lymphokines during renal allograft rejection. The aim of the present investigation was to study simultaneously IL-2, IL-3, IL-4, IL-6, IL-8, and soluble CD23. Analysis of results has allowed both the prognostic value and any possible interrelationships between the measured cytokines to be determined. We studied 16 renal transplant recipients for the first 14 days after transplantation. Seven patients showed clinical evidence of acute allograft rejection and 5 showed excellent stable graft function with no signs of rejection. Primary nonfunction was seen in 4 patients. The plasma levels of each cytokine were measured by commercially available ELISA and immunoradiometric assay kits. As reported in previous studies, plasma IL-2 levels, whenever found at detectable levels, were predictive of impending graft rejection. Serial monitoring of IL-4 and IL-6 was more reliable for the differential diagnosis of rejection, particularly toward the end of the first week after transplantation. IL-3, IL-8, and soluble CD23 were not diagnostic or predictive of rejection, due to the occurrence of significantly high levels in transplant patients who showed no evidence of clinical rejection. While the value of cytokine monitoring has been shown in this study, it should be remembered that infection, although not seen in these studies, may have a profound affect on the results obtained.
authors.affiliation: Department of Surgery, Medical School, University of Newcastle upon Tyne, England.
authors.forename: N
authors.initials: N
authors.lastname: Kutukculer
authors.forename: K
authors.initials: K
authors.lastname: Clark
authors.forename: K M
authors.initials: KM
authors.lastname: Rigg
authors.forename: J L
authors.initials: JL
authors.lastname: Forsythe
authors.forename: G
authors.initials: G
authors.lastname: Proud
authors.forename: R M
authors.initials: RM
authors.lastname: Taylor
authors.forename: B K
authors.initials: BK
authors.lastname: Shenton
mesh_terms: D015415:Biomarkers / Q000097:blood; D006084:Graft Rejection / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000032:analysis*; D007377:Interleukin-3 / Q000032:analysis*; D015847:Interleukin-4 / Q000032:analysis*; D015850:Interleukin-6 / Q000032:analysis*; D016209:Interleukin-8 / Q000032:analysis*; D016030:Kidney Transplantation / Q000276:immunology*; D011237:Predictive Value of Tests; D011379:Prognosis; D017455:Receptors, IgE / Q000032:analysis*; D013997:Time Factors; D014184:Transplantation, Homologous / Q000276:immunology
chemical_list: D015415:Biomarkers; D007376:Interleukin-2; D007377:Interleukin-3; D015850:Interleukin-6; D016209:Interleukin-8; D017455:Receptors, IgE; D015847:Interleukin-4